STACIE MCCORD
SEARCY, AR NPI 1457355166
Browse related groups: AR Celgene Corporation All categories
General Payments — all program years on this page
$8,238.79
- Category: General Payments
- Program years: PY2018–2024
- Record count: 497
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,358.70 across 70 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,259.70 | 69 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $259.86 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $175.14 | 13 |
| ABBVIE INC. | $147.68 | 8 |
| Janssen Biotech, Inc. | $143.89 | 3 |
| GlaxoSmithKline, LLC. | $115.98 | 6 |
| Merck Sharp & Dohme Corporation | $65.71 | 4 |
| Daiichi Sankyo Inc. | $54.02 | 3 |
| PFIZER INC. | $53.20 | 3 |
| Astellas Pharma US Inc | $44.06 | 2 |
| EISAI INC. | $41.67 | 2 |
| Genentech USA, Inc. | $36.54 | 2 |
| GENZYME CORPORATION | $35.95 | 2 |
| Gilead Sciences, Inc. | $34.42 | 2 |
| Mirati Therapeutics, Inc. | $31.34 | 2 |
| Incyte Corporation | $22.40 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.35 | 1 |
| Rigel Pharmaceuticals, Inc. | $18.20 | 1 |
| Lilly USA, LLC | $16.50 | 1 |
| BeiGene USA, Inc. | $15.72 | 1 |
| PharmaEssentia USA Corporation | $14.36 | 1 |
| Pharmacosmos Therapeutics Inc. | $13.71 | 1 |
By program year
Records — PY2024 (70)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.